Inventor · disambiguated record
J. Andrew Bristol
Also filed as: BRISTOL J ANDREW
16 granted patents·1 pending application·231 citations·filing 2006–2024
94Inventor score
Top patents by PatentIndex Score
17 records- 0197US11952429B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2022·Granted Apr 9, 2024·2 cites·22 claims
- 0297US7314622B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersNEOGENIX ONCOLOGY INC·Filed 2006·Granted Jan 1, 2008·111 cites·8 claims
- 0395US7829678B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersNEOGENIX ONCOLOGY INC·Filed 2008·Granted Nov 9, 2010·30 cites·17 claims
- 0492US12344676B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2024·Granted Jul 1, 2025·0 cites·7 claims
- 0592US11401341B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2020·Granted Aug 2, 2022·2 cites·20 claims
- 0692US8802090B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersBRISTOL J ANDREW·Filed 2011·Granted Aug 12, 2014·16 cites·10 claims
- 0792US8524456B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersBRISTOL J ANDREW·Filed 2010·Granted Sep 3, 2013·15 cites·14 claims
- 0891US7763720B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersNEOGENIX ONCOLOGY INC·Filed 2007·Granted Jul 27, 2010·18 cites·29 claims
- 0990US10023650B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2016·Granted Jul 17, 2018·5 cites·20 claims
- 1088US9605077B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2015·Granted Mar 28, 2017·5 cites·18 claims
- 1188US8535667B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersARLEN MYRON·Filed 2010·Granted Sep 17, 2013·8 cites·11 claims
- 1287US9169326B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersARLEN MYRON·Filed 2011·Granted Oct 27, 2015·7 cites·16 claims
- 1386US9371375B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOG INC·Filed 2014·Granted Jun 21, 2016·8 cites·20 claims
- 1485US12460013B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2022·Granted Nov 4, 2025·0 cites·12 claims
- 1585US10364295B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2017·Granted Jul 30, 2019·3 cites·19 claims
- 1684US11572413B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2019·Granted Feb 7, 2023·1 cites·14 claims
- 1769US2018346594A1Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when J. Andrew Bristol files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →